Connect with us

Technology

Colors Genomics partners with MIT, Harvard, and NIH for nationwide biomedical research project

Published

on


kit_contents Color GenomicsCourtesy Color Genomics


  • Color Genomics

    on Tuesday announced
    a partnership with several
    universities for a nationwide study of genetics and
    health. 
  • It will serve as one of the three genome centers in the

    “All of Us” research program
  • Color will be responsible for analyzing and reporting genomic
    data for a set of genes that can cause preventable medical
    conditions. 

In an ambitiously large, nationwide population health
study, genetics startups and heavy-weights are collaborating
together to analyze a wide array of genetic data to see if there
are any clues for prevention and treatment of diseases like
cancer and high cholesterol.


Genetic testing company Color Genomics
 announced on
Tuesday a partnership with MIT and Harvard’s Broad Institute as
well as the Laboratory for Molecular Medicine at Partners
Healthcare in order to establish a genome center for a
nationwide, National Institutes of Health-funded research
project. 

The project, called the “All of Us” research program, will use
three genome centers across the country to collect data from
over 1 million participants from diverse backgrounds nationwide.
The data will be de-identified to find treatments and prevention
strategies for genetic-related medical conditions. 

To partake in the project, participants share personal
information, access to electronic health records, as well as
blood and urine samples. Over 110,000 people have registered for
the program, and over half of them have completed all the
requirements. 

The genome centers will then analyze the genetic data and collect
information about a set of 59 genes known to be associated with
risks of preventable diseases and conditions. These
include breast and ovarian cancer, familial
hypercholesterolemia, and Lynch syndrome. Then the centers
will
 test out pharmacogenomic drug interactions that
could help researchers develop future treatments and
therapeutics.  

Color Genomics,
a competitor to 23andMe,
launched in 2016 to provide
consumers with genetic tests that allow them to
gauge their risk for different hereditary cancers and high
cholesterol
. It had previously partnered with
universities to provide its genetic tests for free
alongside a genetic counselor. 

All of Us is a tremendous
opportunity to unlock the benefits of genetic information to
better understand disease and help people live healthier lives,”
Color CEO Othman Laraki said in the
press release

See also:


Business Insider Intelligence Exclusive FREE Report: The 5 Ways AI Will Change U.S. Healthcare


Continue Reading
Advertisement Find your dream job

Trending